Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 698 | 829 | 725 | 2,952 | 962 |
| Gross Profit | 698 | 829 | 725 | 2,952 | 962 |
| Operating Expenses | 3,511 | 3,897 | 3,758 | 5,137 | 8,183 |
| Operating Income | -2,813 | -3,068 | -3,033 | -2,185 | -7,221 |
| Other Income | 179 | 33 | 43 | 54 | 81 |
| Pre-tax Income | -2,634 | -3,035 | -2,991 | -2,131 | -7,140 |
| Net Income Continuous | -2,634 | -3,035 | -2,991 | -2,131 | -7,140 |
| Net Income | $-2,634 | $-3,035 | $-2,991 | $-2,131 | $-7,140 |
| EPS Basic Total Ops | -4.32 | -28.81 | -8.16 | -5.76 | -24.01 |
| EPS Basic Continuous Ops | -4.27 | -7.33 | -7.53 | -5.38 | -18.41 |
| EPS Diluted Total Ops | -4.32 | -28.81 | -8.16 | -5.76 | -24.01 |
| EPS Diluted Continuous Ops | -4.27 | -7.33 | -7.53 | -5.38 | -18.41 |
| EBITDA(a) | $-2,565 | $-2,904 | $-2,804 | $-1,970 | $-7,030 |